NATCAPSUQPharmaceuticals
Natural Capsules Ltd — Profit & Loss Statement
₹144.35
-2.36%
Natural Capsules Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | -0.16 Cr | -0.02 Cr | -0.02 Cr | -0.77 Cr | — |
| Tax Rate For Calcs | 0.30 | 0.31 | 0.26 | 0.29 | — |
| Normalized EBITDA | 18.74 Cr | 21.91 Cr | 35.69 Cr | 29.04 Cr | — |
| Total Unusual Items | -0.52 Cr | -0.06 Cr | -0.09 Cr | -2.66 Cr | — |
| Total Unusual Items Excluding Goodwill | -0.52 Cr | -0.06 Cr | -0.09 Cr | -2.66 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 0.62 Cr | 5.55 Cr | 18.45 Cr | 13.91 Cr | — |
| Reconciled Depreciation | 9.12 Cr | 8.67 Cr | 7.21 Cr | 5.04 Cr | — |
| Reconciled Cost Of Revenue | 88.43 Cr | 82.36 Cr | 81.91 Cr | 61.49 Cr | — |
| EBITDA | 18.22 Cr | 21.85 Cr | 35.61 Cr | 26.39 Cr | — |
| EBIT | 9.10 Cr | 13.18 Cr | 28.40 Cr | 21.35 Cr | — |
| Net Interest Income | -6.39 Cr | -4.35 Cr | -3.36 Cr | -1.87 Cr | — |
| Interest Expense | 6.31 Cr | 5.13 Cr | 3.41 Cr | 1.96 Cr | — |
| Interest Income | 0.15 Cr | 0.92 Cr | 0.37 Cr | 0.21 Cr | — |
| Operating Expense | 66.70 Cr | 58.61 Cr | 55.57 Cr | 45.42 Cr | — |
| Other Operating Expenses | 24.30 Cr | 23.00 Cr | 24.45 Cr | 19.74 Cr | — |
| Depreciation And Amortization In Income Statement | 9.12 Cr | 8.67 Cr | 7.21 Cr | 5.04 Cr | — |
| Amortization | 0.48 Cr | 0.63 Cr | 0.63 Cr | 0.16 Cr | — |
| Depreciation Income Statement | 8.64 Cr | 8.03 Cr | 6.58 Cr | 4.88 Cr | — |
| Research And Development | 1.60 Cr | 2.08 Cr | 2.39 Cr | 2.12 Cr | — |
| Selling General And Administration | 15.83 Cr | 10.79 Cr | 12.99 Cr | 10.16 Cr | — |
| Selling And Marketing Expense | 13.96 Cr | 8.75 Cr | 11.32 Cr | 8.31 Cr | — |
| General And Administrative Expense | 1.87 Cr | 2.05 Cr | 1.66 Cr | 1.85 Cr | — |
| Rent And Landing Fees | 0.00 | 0.00 | — | — | — |
| Gross Profit | 75.73 Cr | 68.93 Cr | 82.81 Cr | 68.38 Cr | — |
| Cost Of Revenue | 88.43 Cr | 82.36 Cr | 81.91 Cr | 61.49 Cr | — |
| Total Revenue | 164.15 Cr | 151.29 Cr | 164.72 Cr | 129.88 Cr | — |
| Operating Revenue | 164.15 Cr | 151.29 Cr | 164.72 Cr | 129.88 Cr | — |
| Normalized Income | 0.98 Cr | 5.60 Cr | 18.51 Cr | 15.80 Cr | — |
| Net Income From Continuing And Discontinued Operation | 0.62 Cr | 5.55 Cr | 18.45 Cr | 13.91 Cr | — |
| Total Expenses | 155.13 Cr | 140.97 Cr | 137.48 Cr | 106.91 Cr | — |
| Rent Expense Supplemental | 0.00 | 0.00 | — | — | — |
| Diluted Average Shares | 0.98 Cr | 0.93 Cr | 0.93 Cr | 0.70 Cr | — |
| Basic Average Shares | 0.98 Cr | 0.93 Cr | 0.93 Cr | 0.70 Cr | — |
| Diluted EPS | 0.63 | 5.97 | 19.86 | 19.84 | — |
| Basic EPS | 0.63 | 5.97 | 19.86 | 19.84 | — |
| Diluted NI Availto Com Stockholders | 0.62 Cr | 5.55 Cr | 18.45 Cr | 13.91 Cr | — |
| Net Income Common Stockholders | 0.62 Cr | 5.55 Cr | 18.45 Cr | 13.91 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 0.62 Cr | 5.55 Cr | 18.45 Cr | 13.91 Cr | — |
| Net Income Including Noncontrolling Interests | 0.62 Cr | 5.55 Cr | 18.45 Cr | 13.91 Cr | — |
| Net Income Continuous Operations | 0.62 Cr | 5.55 Cr | 18.45 Cr | 13.91 Cr | — |
| Tax Provision | 2.17 Cr | 2.50 Cr | 6.55 Cr | 5.47 Cr | — |
| Pretax Income | 2.79 Cr | 8.05 Cr | 24.99 Cr | 19.39 Cr | — |
| Other Non Operating Income Expenses | 0.56 Cr | 1.02 Cr | 0.15 Cr | 0.74 Cr | — |
| Special Income Charges | -0.52 Cr | -0.06 Cr | -0.09 Cr | -2.66 Cr | — |
| Write Off | 0.52 Cr | 0.06 Cr | 0.13 Cr | 2.72 Cr | — |
| Net Non Operating Interest Income Expense | -6.39 Cr | -4.35 Cr | -3.36 Cr | -1.87 Cr | — |
| Total Other Finance Cost | 0.22 Cr | 0.14 Cr | 0.32 Cr | 0.12 Cr | — |
| Interest Expense Non Operating | 6.31 Cr | 5.13 Cr | 3.41 Cr | 1.96 Cr | — |
| Interest Income Non Operating | 0.15 Cr | 0.92 Cr | 0.37 Cr | 0.21 Cr | — |
| Operating Income | 9.03 Cr | 10.32 Cr | 27.24 Cr | 22.97 Cr | — |
| Other Special Charges | — | — | -0.05 Cr | -0.06 Cr | -90000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Natural Capsules Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.